Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.89 -0.06 (-0.86%)
As of: Sep 4, 2026 · 12:51 PM EDT

Ginkgo Bioworks Holdings (DNA) Minority Interest (2020 - 2022)

Ginkgo Bioworks Holdings' (DNA) quarterly Minority Interest came in at $5.0 million in Q3 2022, down 92.47% YoY from $66.4 million in Q3 2021, and down 84.19% on a QoQ basis from $31.6 million in Q2 2022.

Analysis

Ginkgo Bioworks Holdings (DNA) Minority Interest (2020 - 2022) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has 3 years of Minority Interest data on file, last reported at $5.0 million in Q3 2022.

  • Quarterly Minority Interest fell 92.47% year-over-year to $5.0 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $5.0 million (down 92.47% YoY) and the FY2021 annual result came in at $62.0 million, up 614.78% from the prior year.
  • Minority Interest retreated to $5.0 million in Q3 2022, from $31.6 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $66.4 million in Q3 2021 to a low of $5.0 million in Q3 2022.
  • A 3-year average of $34.5 million and a median of $32.4 million in 2022 frame the typical range for Minority Interest.
  • Annual changes were most pronounced in 2021 — Minority Interest surged 614.78% — and 2022, when it plunged 92.47%.
  • Tracing DNA's Minority Interest over 3 years: stood at $8.7 million in 2020, then jumped by 614.78% to $62.0 million in 2021, then slumped by 91.94% to $5.0 million in 2022.
  • The last three Minority Interest figures came in at $5.0 million (Q3 2022), $31.6 million (Q2 2022), and $33.3 million (Q1 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Ginkgo Bioworks Holdings 427.52 Mn 342.98 Mn 18.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 5.00 Mn
Jun 30, 2022 31.63 Mn
Mar 31, 2022 33.25 Mn
Dec 31, 2021 62.01 Mn
Sep 30, 2021 66.42 Mn
Dec 31, 2020 8.68 Mn